Nanoemulsion Adjuvanted Vaccines Continue to Demonstrate Positive Pre-Clinical Results in Genital Herpes, HIV and Chlamydia

NanoBio Corporation, a biopharmaceutical company focused on developing and commercializing intranasal and intramuscular vaccines, today announced that its intranasal nanoemulsion (NE) adjuvanted chlamydia vaccine has demonstrated efficacy in a traditional mouse challenge model. The study was conducted by leading chlamydia vaccine researchers at the Queensland University of Technology (QUT) in Brisbane, Australia led by Dr. … Continued

Delphinus Adds Vice President of Quality, Regulatory Affairs to Team

Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced today that it has appointed Francis X. Dobscha as its new vice president of quality and regulatory affairs.  With more than 30 years of experience in healthcare, Dobscha will lead the organization’s quality efforts and guide the regulatory submissions as the company continues clinical … Continued